A new study conducted at the Penn State Cancer Institute in Hershey, Pennsylvania, purports that "women with advanced breast cancer who undergo surgery to remove the tumor after chemotherapy or another type of systemic treatment may live longer than those who don't have surgery." Study author Dr. Daleela Dodge further explains that the surgery for metastatic breast cancer patients should be considered as a plausible alternative to systematic treatment, which is currently the standard of care offered to these patients.
To read more about this study, click here.
SOURCES: Daleela Dodge, MD, associate professor, surgery, Penn State Cancer Institute, Hershey, Pa.; Stephanie Bernik, MD, chief, breast service, Mount Sinai West Medical Center, New York City, and associate professor, surgery, Icahn School of Medicine at Mount Sinai, New York City; Annals of Surgical Oncology, Oct. 30, 2020
No comments:
Post a Comment